| Metric | Value | Detail |
|---|---|---|
| Revenue | $10.1B | +20.5% YoY |
| Net income | $2.9B | 28.4% margin |
| Gross margin | 66.0% | Gross profit / revenue |
| Operating margin | 29.3% | Operating income / revenue |
| Return on equity | 16% | Net income / equity |
| Return on assets | 14% | Net income / assets |
| Revenue growth (YoY) | +20.5% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | +17.4% | Compound annual |
| Diluted EPS | $7.87 | FY2025 |
| Debt-to-equity | n/a | No long-term debt figure in the SEC data |
| Current ratio | 4.87 | Current assets / liabilities |
| Cash & equivalents | $3.4B | Balance sheet |
| Total assets | $20.5B | FY2025 year-end |
| Shareholders’ equity | $17.8B | FY2025 year-end |
| Share price | $394.40 | Delayed · 2026-10-02 |
| Market cap | $139.3B | Price × shares outstanding |
| P/E ratio | 48.8 | Market cap / net income |
| P/S ratio | 13.8 | Market cap / revenue |
| Dividend yield | n/a | No dividend in the SEC data |
Stock fundamentals · FY2025 · SEC 10-K data
Intuitive Surgical, Inc. (ISRG) stock fundamentals
Intuitive Surgical, Inc. (ISRG) reported $10.1B in revenue and $2.9B in net income in fiscal 2025, a 28.4% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $139.3B at a delayed share price. It scores 68/100 on WealthyBud's Investor Score, ranking #13 of 103 covered companies. Score is research, not investment advice.
Revenue (FY2025)
$10.1B
▲ +20.5% YoY
Net income
$2.9B
28.4% net margin
Market cap
$139.3B
Price $394.40 · delayed
P/E ratio
48.8
Price / earnings
Return on equity
16%
Net income / equity
Investor Score
68/100
#13 of 103 covered
Intuitive Surgical, Inc. fundamentals at a glance
The table summarizes Intuitive Surgical, Inc.'s key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is Intuitive Surgical, Inc.?
Intuitive Surgical, Inc. posted a 28.4% net margin and a 66.0% gross margin in fiscal 2025, turning $10.1B of revenue into $2.9B of net income. Its return on equity was 16% and its return on assets 14%.
Is Intuitive Surgical, Inc. growing?
Intuitive Surgical, Inc.'s revenue changed +20.5% in fiscal 2025 and compounded at +17.4% a year over three years, reaching $10.1B. Diluted earnings per share were $7.87 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $5.7B | First year shown |
| 2022 | $6.2B | +9.0% |
| 2023 | $7.1B | +14.5% |
| 2024 | $8.4B | +17.2% |
| 2025 | $10.1B | +20.5% |
How is Intuitive Surgical, Inc. valued?
Intuitive Surgical, Inc. carries a market capitalization of $139.3B at a delayed share price of $394.40. It trades at 48.8 times earnings and 13.8 times sales. Its dividend yield is not shown because its SEC data shows no dividend for the year. Its Value subscore is 19/100 across the covered universe.
How financially healthy is Intuitive Surgical, Inc.?
Intuitive Surgical, Inc. ended fiscal 2025 with $3.4B in cash, a debt-to-equity ratio that is not available because the SEC data has no long-term debt figure and a current ratio of 4.87. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is Intuitive Surgical, Inc.'s Investor Score?
Intuitive Surgical, Inc. scores 68/100 on WealthyBud's Investor Score, #13 of 103 covered companies as of 2026-10-02. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Investor Score
68/100
#13 of 103 covered companies
Subscores are percentile ranks (0–100) across the 103 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
Intuitive Surgical, Inc. (ISRG) stock FAQ
How much revenue does Intuitive Surgical, Inc. make?
Intuitive Surgical, Inc. (ISRG) reported $10.1B in revenue in fiscal 2025, +20.5% versus the prior year, according to its SEC 10-K filing. Its revenue compounded at +17.4% a year over three years.
Is Intuitive Surgical, Inc. profitable?
Yes. Intuitive Surgical, Inc. earned $2.9B in net income in fiscal 2025, a 28.4% net margin. Its return on equity was 16% and its return on assets 14%. These figures come from its latest 10-K.
How fast is Intuitive Surgical, Inc. growing?
Intuitive Surgical, Inc.'s revenue changed +20.5% year over year in fiscal 2025 and compounded at +17.4% a year over three years. Growth is one of five inputs to its WealthyBud Investor Score, scored 81/100 versus the covered universe.
What is Intuitive Surgical, Inc.'s market cap and P/E ratio?
Intuitive Surgical, Inc. has a market capitalization of $139.3B at a delayed share price of $394.40. It trades at 48.8 times earnings and 13.8 times sales. Its dividend yield is not shown because its SEC data shows no dividend for the year. Prices are delayed and illustrative.
What is Intuitive Surgical, Inc.'s WealthyBud Investor Score?
Intuitive Surgical, Inc. scores 68/100, ranking #13 of 103 covered companies as of 2026-10-02. The score is a percentile blend of growth (81), profitability (73), returns on capital (58), balance-sheet strength (99) and value (19). It is a research opinion, not investment advice.
Where does this Intuitive Surgical, Inc. financial data come from?
Fundamentals come from Intuitive Surgical, Inc.'s annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from Intuitive Surgical, Inc.’s FY2025 Form 10-K filed with the
SEC (EDGAR, public domain), retrieved 2026-10-02. Share price is a delayed end-of-day quote; market cap, P/E, P/S
and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion.
Not investment advice.
Related
More large-cap stocks
Stocks
Uber Technologies, Inc (UBER)
$139.1B market cap · Investor Score 65/100
View StocksServiceNow, Inc. (NOW)
$139.8B market cap · Investor Score 53/100
View StocksVERTEX PHARMACEUTICALS INC (VRTX)
$127.8B market cap · Investor Score 65/100
View ResearchU.S. Stock Market Statistics (2026)
Market cap, valuation and concentration data across the U.S. stock market.
View